Skip to main content

Table 3 Effect of flaxseed oil supplementation on AEA status

From: Effect of flaxseed oil supplementation on the erythrocyte membrane fatty acid composition and endocannabinoid system modulation in patients with coronary artery disease: a double-blind randomized controlled trial

VariableFlaxseed oil (n = 21)Placebo (n = 19)MD (95% CI), P value
AEA (ng/ml)
 Before5.45 (2.98)6.76 (2.72)1.31 (− 0.54 to 3.17), 0.158a
 After4.73 (2.67)6.44 (2.44)0.64 (0.12 to 1.15), 0.016b
MD (95% CI), P valuec− 0.71 (− 1.08 to − 0.34), 0.001− 0.32 (− 0.70 to 0.05), 0.091 
  1. Values are expressed as mean (SD)
  2. AEA N-arachidonoyl ethanolamine, MD mean difference
  3. aIndependent samples t-test
  4. bAdjusted for baseline values, weight differences, energy intake changes and fat intake changes using the analysis of covariance (ANCOVA) test
  5. cPaired-samples t-test